2023 annual financial data
Fate Therapeutics 2023 Net margin
Fate Therapeutics 2023 net margin with verified reported values.
Direct answer
Net margin was -253.3%.
Operating income was -190,511,000 USD and net income was -160,928,000 USD.
Operating cash flow was -132,263,000 USD.
Get free Fate Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 63,533,000 USD
- Operating income
- -190,511,000 USD
- Net income
- -160,928,000 USD
- Operating cash flow
- -132,263,000 USD